Trials / Conditions / Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

9 registered clinical trials studyying Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno NCT05041153	M.D. Anderson Cancer Center	EARLY_Phase 1
Recruiting	Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv NCT04660760	Academic and Community Cancer Research United	Phase 2
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937	National Cancer Institute (NCI)	Phase 1
Recruiting	Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol NCT04771520	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer NCT04522336	M.D. Anderson Cancer Center	Phase 1
Recruiting	Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893	University of California, San Francisco	N/A
Active Not Recruiting	Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer NCT04220827	M.D. Anderson Cancer Center	Phase 1
Completed	Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574	National Cancer Institute (NCI)	—
Completed	IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga NCT03918499	City of Hope Medical Center	Phase 1 / Phase 2